For Biotech Investors: 5 Orphan Drugs and Their Parent Companies

For Biotech Investors: 5 Orphan Drugs And Their Parent Companies

Filed under: drug treatment news

Drugs that treat rare diseases generally cost a lot more as well, which means that orphan drugs can be extremely high-margin sources of income. Here are promising orphan drugs and their parent companies that have garnered a lot of interest from …
Read more on Seeking Alpha

Cipla slashes prices of cancer drugs

Filed under: drug treatment news

The drugs are used for treating lung and pancreatic cancer, breast cancer, head and neck cancer, gastric cancer, bladder and colorectal and colon cancers, it added. The lung cancer drug Erlocip will now cost Rs.9,900 for 30 tablets against its earlier …
Read more on The Hindu

Treatment for Rare Genetic Diseases of Liver Granted Orphan Drug Designation

Filed under: drug treatment news

Albireo AB announced that A4250 has been granted orphan-drug designation by the FDA for the treatment of progressive familial intrahepatic cholestasis (PFIC) and primary biliary cirrhosis (PBC). A4250 belongs to a class of inhibitors of the ileal bile …
Read more on Monthly Prescribing Reference